Biomedical advances have brought improved treatment for HIV/AIDs, but how accessible is innovation beyond the rich, developed world? And have healthcare systems been able to exploit this new availability of advanced drugs?
This is the second podcast recorded during our meeting on Financing continued scale-up in HIV treatment: more money for years gained and more years gained for the money.
Listen to the first podcast What investment in the future?
Ernest Darkoh, Founding Partner, BroadReach Healthcare, Johannesburg
Shannon Kowalski, Senior Program Officer, The Open Society Foundations, New York
John Martin. Chairman, Board of Directors and Chief Executive Officer, Gilead Sciences Inc, Foster City CA.